Professor Warwick Anderson AM is the Chief Executive Officer (CEO) of NHMRC, Australia’s major governmental funding body for health and medical research. Previously, he was Head of School of Biomedical Sciences at Monash University and Deputy Director of the Baker Medical Research Institute, following research fellowships at the University of Sydney and Harvard Medical School.
Professor Anderson obtained his PhD from the University of Adelaide. His research has focused on renal causes of hypertension, including the roles of renal vascular remodeling, renal innervation and the renin-angiotensin system. He has published over 170 peer review articles.
Professor Anderson is a Board member of the Global Alliance for Chronic Disease, a member of Heads of International (Biomedical) Research Organizations. He is an Honorary Fellow of the Royal College of Pathologists of Australasia and an International Fellow of the Council for High Blood Pressure of the American Heart Foundation. He serves on the National Science, Technology and Research Committee, and the CRC Committee. He is a member of the International Advisory Committee on Biomedical Science for Singapore. He was made a Member of the Order of Australia in 2005.
He has been appointed Secretary-General, Human Frontier Science Program effective from July 2015.
NHMRC Statement of Intent
The 2010 Statement of Intent sets out the CEO's plan for the NHMRC to achieve the activities outlined in the Minister for Health and Ageing's Statement of Expectation.